For the past six months Pfizer, a leading drug company, has been selling a drug in Europe that treats a rare and deadly disease. The drug has received dozens of approvals around the world and now that it has seen some real world use the drug has finally spread to the United States. Proponents for the drug claim that it could save countless lives each year and as a result the FDA is now entering the first stage of possibly approving the drug for use in America.
The drug treats a relatively uncommon neurological disease but many doctors and analysts feel it might actually be able to treat or reduce the effects of many other similar disease. Pfizer has, for many reasons, been pushing for the drug to be available in America and now that the FDA is looking at it we might be one step closer to making that a reality.
This is great news for thousands of people directly affected by the disease, but more importantly it shows that around the world medical expertise and research is being shared and expanded. Medicines are treating new diseases every single day and as the years pass it is only a matter of time before some sort of viable medicine becomes available for any number of major issue. The FDA has not yet said when they will begin the proceedings but it is expected to begin sometime in the coming month.